Compound Tag
Hexarelin
5 research articles in this compound library
Compound Index
Peptide Water Retention and Electrolyte Research: What the Data Shows
A researcher's guide to understanding water retention, sodium balance, and electrolyte endpoints in peptide studies — covering MK-677, GH secretagogues, GLP-1 agonists, and aldosterone-pathway interactions. Includes study design recommendations and measurement protocols.
IGF-1 in Peptide Research: Why It's the Key Biomarker
IGF-1 is the primary endpoint for GH axis peptide research. This guide covers IGF-1 biology (GHR/JAK2/STAT5b), normal reference ranges, published IGF-1 elevation data for all major GH secretagogues, sampling timing requirements, confounders (nutrition, sex, age, stress), ELISA selection guidance, and a full research design framework for using IGF-1 as your primary endpoint.
MK-677 vs Ipamorelin vs CJC-1295: Which GH Secretagogue for Your Research?
A comparative research guide to MK-677 (ibutamoren), ipamorelin, and CJC-1295 No DAC — covering mechanisms, published IGF-1 data, half-life differences, pulsatile vs continuous GH elevation, and a decision matrix for choosing the right compound for your study design.
Hexarelin: The Forgotten GHRP with Cardiac Effects
A research-focused review of Hexarelin — a synthetic GHRH secretagogue with unique GHSR-1a and CD36 dual receptor pharmacology, superior GH release potency among GHRPs, documented cardiac cytoprotective effects, and a distinct tachyphylaxis profile that shapes research design decisions.
Ipamorelin vs GHRP-2 vs GHRP-6: Growth Hormone Secretagogue Comparison
A head-to-head comparison of three leading growth hormone secretagogues — ipamorelin, GHRP-2, and GHRP-6. Covers selectivity, ghrelin receptor binding, hunger side effects, published study data, and dosing protocols used in preclinical research.